VR Stroke Rehabilitation Market Worth US$ 376 Billion by 2033 Globally, at a CAGR of 9.2%, Says Future Market Insights, Inc.


<!– Name:DistributionId Value:8836141 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:5557 –> <!– Name:CustomerId Value:1095645 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:19200af3-c26a-4e28-9dec-c17678f202fa –>

NEWARK, Del, May 10, 2023 (GLOBE NEWSWIRE) — As per Future Market Insights’ latest industry analysis, the valuation for the global VR stroke rehabilitation market was around US$ 144.9 Billion in 2022 and is projected to exhibit a CAGR of 9.2% over the forecast period, with an estimated valuation of US$ 376.0 Billion in 2033.

It’s critical to investigate the opportunities presented by cutting-edge technology considering the widespread nature of brain damage in the population and the requirement for new rehabilitation tools.

By providing new chances for learning, to respond to and accomplish activities in less complex ways that involve a simplified cognitive load, greater repetition, and progressive training compared to real-world tasks, virtual reality (VR) has the potential to support current rehabilitation procedures.

Get Sample Report with Latest Industry Trends Analysis: https://www.futuremarketinsights.com/reports/sample/rep-gb-17044

Physical exercise and cognitive training can be used alone or together, depending on the therapeutic goal. In connection with this, VR enables the delivery of well calibrated multimodal stimuli for information feedback or errorless learning techniques.

Consumers and vendors are collaborating to create cutting-edge products that increase sales and profits for both sides, because of which organizations and manufacturers with advanced procurement processes are getting the opportunity to grow and extend their businesses. By incorporating various tactics into their operations, they adopt innovative techniques and take an integrated approach to product development.

While NIBS (non-invasive brain stimulation) may change the neurophysiology underlying cognitive functioning, VR offers a controlled and alluring environment that can be tailored to the patient’s demands. Many studies have suggested that using these technologies in combination may be more effective for this objective than using them separately.

For example, it has been used to treat spider phobia, induce embodiment for an artificial hand, and intervene with a variety of populations, including healthy adults, post-stroke patients, and children with cerebral palsy.

Key Takeaways from Market Study

  • Long term patients are the leading segment as patient type, and held 69.2% market value share in 2022, owing to increasing sale of VR Stroke Rehabilitation market.
  • By service provider, rehabilitation centers held a share of around 36.6% in 2022; because they offer the resources, knowledge, and technology required to create effective treatments for stroke victims.
  • North America held a value share of around 40.9% in 2022, owing to the significant number of VR Stroke Rehabilitation procedures conducted in the region.

“Increasing demand for VR Stroke Rehabilitation procedures and the increasing prevalence of neurodegenerative diseases will boost the global market for VR Stroke Rehabilitation. Says an analyst of Future Market Insights.

View Full Report Details: https://www.futuremarketinsights.com/reports/vr-stroke-rehabilitation-market

Market Competition

Presently, virtual reality (VR) has become a cutting-edge therapy option for rehabilitation. Particularly in hospital settings, VR for Stroke Rehabilitation using commercial game consoles is gaining acceptance. Using VR, stroke victims can receive treatment in a digitally created virtual world, and the data gathered is sent to a specialist for more research.

The market for VR Stroke Rehabilitation represents a consolidated market with players focussed on providing technology driven platforms to the end users.

  • Saebo, Inc. got approval from the U.S. Food and Drug Administration in July 2017 for SaeboVR, a virtual reality rehabilitation system designed for neurological patients who struggle with both cognitive and physical issues.
  • Oxford VR’s (UK) robotic virtual reality therapy was released in April 2020 and featured in the NHSX Global Digital Exemplar. The NHS’s Improving Access to Psychological Therapies (IAPT) services, which provide mental health care, have embraced and integrated the business’s initiative.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the VR Stroke Rehabilitation market in its latest study, presenting a historical demand assessment of 2012 to 2022 and projections for 2023 to 2033. The global VR Stroke Rehabilitation market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The research study is based on the patient type (short-term patients, long-term patients), by service provider (hospitals, clinics, rehabilitation centers, homecare settings), across seven key regions of the world.

Any question concerning VR stroke rehabilitation market report or additional info click here: https://www.futuremarketinsights.com/ask-question/rep-gb-17044

Key Market Segments Covered in the VR Stroke Rehabilitation Industry Research

Patient Type:

  • Short Term Patients
  • Long Term Patients

Service Provider:

  • Hospitals
  • Clinics
  • Rehabilitation Centers
  • Homecare settings


  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Table of Content

1. Executive Summary | VR Stroke Rehabilitation Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations

2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development/Innovation Trends

4. Key Success Factors
4.1. Service Adoption Analysis
4.2. Stroke Prevalence Rate
4.3. Regulatory Landscape
4.4. PESTLE Analysis
4.5. Porter’s Analysis (TOC Continue…)

Get a 20% Flat Discount (Apply FMITODAY Promo Code) on Direct Purchase: https://www.futuremarketinsights.com/checkout/17044

Have a Look at Related Reports of Healthcare domain

Antidiabetics Market Size: The industry is estimated to reach US$ 223 Billion, displaying a CAGR of 9.6% during the assessment period from 2022- to 2032.

Disposable Blood Pressure Cuffs Market Share: The disposable blood pressure cuffs market is projected to acquire a CAGR of 12.3% from 2022 to 2032.

Home Rehabilitation Services Market Demand: The global home rehabilitation services market totaled US$ 84.1 Billion in 2021. Sales in the home rehabilitation services market are slated to increase at a CAGR of 4.8%, to reach US$ 140.5 Billion by 2032.

Epinephrine Auto-Injectors Market Growth: The market for epinephrine auto-injectors is estimated to reach US$ 3.2 billion by 2032, up from US$ 2 billion in 2022, at a CAGR of 4.9% between 2022 and 2032.

Healthcare Biometrics Market Trends: The healthcare biometrics market is anticipated to grow with a CAGR of 18.1% from 2022 to 2032. healthcare biometrics manufacturers are anticipated to generate high revenue of US$ 17.9 Billion by 2032.

Diabetic Retinopathy Market Analysis: The diabetic retinopathy market is likely to grow with an estimated CAGR of 5.8% from 2022 to 2032. diabetic retinopathy manufacturers are anticipated to generate high revenue of US$ 14.8 Billion by 2032.

Electrosurgery Devices Market Forecast: The electrosurgery devices market is expected to strengthen its hold on the global market at a strong CAGR of 4.4% between 2022 and 2032. The market is valued at US$ 3.3 Billion in 2022 and is likely to reach US$ 5.1 Billion by 2032.

Cosmetic Implants Market Status and Prospects: The global cosmetic Implants market garnered US$ 9.6 Billion in 2021, and the market is likely to propel to US$ 17.9 Billion by 2032.

Neuroendoscopy Devices Market Overview: The neuroendoscopy devices market is anticipated to have an effective CAGR of 7.6% during the period of 2022 to 2032.

Novel Drug Delivery Systems In Cancer Therapy Market Outlook: The novel drug delivery systems in the cancer therapy market are anticipated to have a thriving CAGR of 19.6% during the period of 2022 to 2032.

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
Tel: +1-845-579-5705
Email: [email protected]
Web: www.futuremarketinsights.com
LinkedIn | TwitterBlogs | YouTube